SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Oncology Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1078155208094101v1
15/1/5    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kanate, A. S
Right arrow Articles by Higa, G. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanate, A. S
Right arrow Articles by Higa, G. M
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Priorities and uncertainties of administering chemotherapy in a pregnant woman with newly diagnosed colorectal cancer

Abraham S Kanate, MD

Mary Babb Randolph Cancer Center, Section of Hematology/ Oncology, Department of Medicine, West Virginia University, Morgantown, WV 26506, USA

Miklos L Auber, MD

Mary Babb Randolph Cancer Center, Section of Hematology/ Oncology, Department of Medicine, West Virginia University, Morgantown, WV 26506, USA

Gerald M Higa, PharmD

Mary Babb Randolph Cancer Center, Section of Hematology/ Oncology, Department of Medicine, West Virginia University, Morgantown, WV 26506, USA, ghiga{at}hsc.wvu.edu

Background. The absence of treatment standards for the use of chemotherapy in pregnancy is due, in part, to the fact that cancer in the gravid female is relatively uncommon.

Method. A case (of a pregnant woman with newly diagnosed colorectal cancer) is presented to explore this area of medical uncertainty.

Result. Managed by a multi-disciplinary team, successful prolongation of gestation was achieved with an oxaliplatin-based chemotherapy regimen.

Conclusion. A perspective of the ongoing conflict between prolonging the mother's life and preserving fetal development is highlighted. Although not life-saving, administration of chemotherapy in this woman was life-sparing. J Oncol Pharm Practice (2009) 15: 5—8.

Key Words: abortion • cancer in pregnancy • chemotherapy • colorectal cancer

This version was published on March 1, 2009

Journal of Oncology Pharmacy Practice, Vol. 15, No. 1, 5-8 (2009)
DOI: 10.1177/1078155208094101


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement